Paragas, Wendy C.
HRN: 22-42-22 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/21/2023
CO-AMOXICLAV 625MG (TAB)
04/21/2023
04/28/2023
PO
625mg
BID X 7days
2nd Degree RMLE
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes